Dhampur Bio Organics FY26 Results and Meerganj Unit Divestment
Dhampur Bio Organics Ltd. reported its financial results for the fiscal year ending March 31, 2026, with total revenue reaching ₹2,082.01 Crore. The company also announced a significant corporate action: the divestment of its Meerganj unit.
What just happened
Dhampur Bio Organics announced its full-year and fourth-quarter financial results for FY26. For the full year, revenue stood at ₹2,082.01 Crore, and Profit After Tax (PAT) was ₹24.97 Crore. In the fourth quarter (Q4 FY26), the company reported revenue of ₹552.44 Crore and PAT of ₹46.00 Crore. EBITDA for FY26 was ₹162.01 Crore, while Q4 FY26 EBITDA was ₹102.44 Crore. Additionally, the company entered into a business transfer agreement on April 20, 2026, to sell its Meerganj unit.
Why this matters
These results showcase the company's top-line performance for the fiscal year and provide a glimpse into its profitability. The divestment of the Meerganj unit is a strategic move that could impact the company's operational footprint and financial structure. Investors will closely watch the implications of this sale on future growth and asset management.
The backstory
Dhampur Bio Organics operates in the sugar and bio-energy sectors. Its consolidated performance reflects its scale across these segments. The company has been focusing on its balance sheet, as indicated by its long-term debt-to-equity ratio.
What changes now
The sale of the Meerganj unit marks a significant shift in the company's operational strategy. Investors should assess how this divestment affects the company's capacity, market presence, and overall business model. The focus may now shift towards optimizing the remaining assets and exploring new avenues for growth.
Risks to watch
Key risks include the successful completion of the Meerganj unit divestment and its financial impact. Future performance will depend on market conditions in the sugar and bio-energy sectors, as well as the company's ability to execute its strategic objectives post-divestment.
Peer comparison
Dhampur Bio Organics operates in the agro-processing and bio-energy space, competing with other integrated sugar and ethanol manufacturers. Performance comparisons would typically involve metrics like revenue growth, EBITDA margins, and debt levels relative to peers.
Context metrics (time-bound)
- Revenue (FY26): ₹2,082.01 Crore
- PAT (FY26): ₹24.97 Crore
- EBITDA (FY26): ₹162.01 Crore
- Long-term Debt to Equity Ratio (as of March 31, 2026): 0.28x
What to track next
Investors should monitor updates regarding the Meerganj unit sale, its financial closure, and any stated plans for capital allocation or business realignment. Performance in the sugar, biofuel, and spirits segments will also be crucial.
Reader Takeaway: Revenue crosses ₹2,000 Cr, but Meerganj unit sale needs investor monitoring.
